Skip to main content
. Author manuscript; available in PMC: 2013 Oct 1.
Published in final edited form as: Pharmacogenet Genomics. 2012 Oct;22(10):750–757. doi: 10.1097/FPC.0b013e328357f6af

Fig. 1.

Fig. 1

Details of the GOLDN study. Reproduced with permission from Frazier-Wood et al. [26]. AE, adverse events; GOLDN, Genetics of Lipid Lowering Drugs and Diet Network.